Antioxidant Vitamin Intake and Risk of Alzheimer Disease
Arch Neurol 60:203-208, Luchsinger,J.A.,et al, 2003
Dietary Antioxidants and the Risk of Ischemic Stroke
Neurol 61:1273-1275, Voko,Z.,et al, 2003
Alzheimer Disease
JAMA 287:2335-2338, Cummings,J.L. &Cole,G., 2002
Intakes of Vitamins E and C, Carotenoids, Vitamin Supplements, and PD Risk
Neurol 59:1161-1169, Zhang,S.M.,et al, 2002
APOE Genotype is a Major Predictor of Long-Term Progression of Disability in MS
Neurol 56:312-316, Chapman,J.,et al, 2001
Apolipoprotein E Genotype and the Risk of Recurrent Lobar Intracerebral Hemorrhage
NEJM 342:240-245,276, O'Donnell,H.C.,et al, 2000
Might Olfactory Dysfunction be a Marker of Early Alzheimer's Disease?
Lancet 355:84-85, Burns,A., 2000
Patterns of Brain Activation in People at Risk for Alzheimer's Disease
NEJM 343:450-456,502, Bookheimer,S.Y. et al, 2000
Antioxidant Therapy in Neurologic Disease
Arch Neurol 57:1265-1270, Delanty,N. & Dichter,M.A., 2000
Vitamin E and Beta Carotene Supplementation in High Risk for Stroke
Arch Neurol 57:1503-1509, Leppala,J.M.,et al, 2000
Warfarin-Associated Hemorrhage and Cerebral Amyloid Angiopathy
Neurol 55:947-951, Rosand,J.,et al, 2000
Intake of Flavonoids, Carotenoids,Vitamins C and E, and Risk of Stroke in Male Smokers
Stroke 31:2301-2306, Hirvonen,T.,et al, 2000
Relation of Consumption of Vitamin E, Vitamin C, and Carotenoids to Risk for Stroke among Men in the United States
Ann Int Med 130:963-970, Ascherio,A.,et al, 1999
Altered Brain Activation in Cognitively Intact Individuals at High Risk for Alzheimer's Disease
Neurol 53:1391-1396, Smith,C.D.,et al, 1999
Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's Disease
NEJM 338:506-511, Mayeux,R.,et al, 1998
The Genetics of Alzheimer Disease, Current Status and Future Prospects
Arch Neurol 55:294-296, Blacker,D.&Tanzi,R.E., 1998
Morality in DATATOP:A Multicenter Trial in Early Parkinson's Disease
Parkinson Study Group, Ann Neurol 43:318-3251998., , 1998
The APOE-e4 Allele and the Risk of Alzheimer Disease Among AFrican Americans, Whites and Hispanics
JAMA 279:751-755, 7881998., Tang,M.,et al, 1998
Smoking and Risk of Dementia and Alzheimer's Disease in a Population-Based Cohort Study:The Rotterdam Study
lancet 351:1840-1843, Ott,A.,et al, 1998
Cerebral Amyloid Angiopathy:Propsects for Clinical Diagnosis and Treatment
Neurol 52:690-694, Greenberg,S.M., 1998
Complete Genomic Screen in Late-Onset Familial Alzheimer Disease, Evidence for a New Locus on Chromosome 12
JAMA 278:1237-1241, 12821997., Pericak-Vance,M.A.,et al, 1997
Association of Apolipoprotein E Polymorphism with Outcome after Head Injury
Lancet 350:1069-1071, Teasdale,G.M.,et al, 1997
Exploring the Etiology of Alzheimer Disease Using Molecular Genetics
JAMA 277:825-831, Lendon,C.L.,et al, 1997
The Clinical Introduction of Genetic Testing for Alzheimer Disease, An Ethical Perspective
JAMA 277:832-836, Post,S.G.,et al, 1997
Herpes Simplex Virus Type 1 in Brain and Risk of Alzheimer's Disease
Lancet 349:241-244, Itzhaki,R.F.,et al, 1997
Apolipoprotein E Genotypes in Primary Progressive Aphasia
Neurol 49:51-55, Mesulam,M.M.,et al, 1997
High Frequency of Apolipoprotein E e2 Allele in Hemorrhage Due to Cerebral Amyloid Angiopathy
Ann Neurol 41:716-721, 7011997., Nicoli,J.A.R.,et al, 1997
Corticobasal Degeneration:Neuropathologic and Clinical Heterogeneity
Neurol 48:959-969, Schneider,J.A.,et al, 1997
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
NEJM 336:1216-1222, 12451997., Sano,M.,et al, 1997
Antioxidants and Dementia
Lancet 349:1189-1190, Lethem,R.&Orrell,M., 1997
Apolipoprotein E e4 Associated with Chronic Traumatic Brain Injury in Boxing
JAMA 278:136-140, Jordan,B.D.,et al, 1997
Dietary Antioxidants and Parkinson Disease
Arch Neurol 54:762-765, deRijk,M.C.,et al, 1997
Genetic Testing for Alzheimer Disease, Practical and Ethical Issues
Arch Neurol 54:1226-1229, Roses,A.D., 1997
Isolated Vitamin E Deficiency
Muscle & Nerve 19:1161-1165996., Jackson,C.E.,et al, 1996
Apolipoprotein E Phenotype Freq & CSF Concentra are not Assoc with Creutzfeldt-Jakob Disease
Arch Neurol 53:1233-1238, Zerr,I.,et al, 1996
Genetic Factors in Alzheimer's Disease:A Review of Recent Advances
Ann Neurol 40:829-840, Levy-Lahad,E.&Bird,T.D., 1996
A Man with Weight Loss, Ataxia, and Confusion for 3 Months
Lancet 347:448, Beversdorf,D.,et al, 1996
Influence of Apolipoprotein E Genotype on Cerebral Amyloid Angiopathy in the Elderly
Stroke 27:216-218, Itoh,Y.,et al, 1996
Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Subjects Not Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:29-361996., , 1996
Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Patients Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:37-451996., , 1996
Clinicopath Conf
Cerebral Amyloid Angiopathy, Case 22-1996, NEJM 335:189-196996., , 1996
Apolipoprotein E e4 is Associated with the Presence and Earlier Onset of Hemorrhage in Cerebral Amyloid Angiopathy
Stroke 27:1333-1337, Greenberg,S.M.,et al, 1996
Apolipoprotein E and Cognitive Decline in Alzheimer's Disease
Neurol 47:317-320, Plassman,B.L.&Breitner,J.C.S., 1996
High Apolipoprotein E e4 Allele Frequency in Age-Related Memory Decline
Ann Neurol 39:548-551, Blesa,R.,et al, 1996
Apolipoprotein E Genotyping in Alzheimer's Disease
Lancet 347:1091-1095, Tanzi,R.,et al, 1996
The Challenge of the Dementias
Lancet 347:1301-1307, Eastwood,R.,et al, 1996
Case-Control Study of Idiopathic Parkinson's Disease and Dietary Vitamin E Intake
Neurol 46:1270-1274, Morens,D.M.,et al, 1996
Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the e4Allele for Apolipoprotein E
NEJM 334:752-758, 7911996., Reiman,E.M.,et al, 1996
The Inherited Ataxias and the New Genetics
JNNP 61:327-332, Hammans,S.R., 1996
Apolipoprotein E Allele E4, Dementia, and Cognitive Decline in a Population Sample
Lancet 346:1387-1390, Henderson,A.S.,et al, 1995